Vnitr Lek 2005, 51(10):1114-1119

The role of apoptosis in cardiovascular diseases

P. Hude
I. interní kardio-angiologická klinika Lékařské fakulty MU a FN u sv. Anny, Brno, přednosta prof. MUDr. Jiří Vítovec, CSc., FESC

Active cell death (apoptosis) represents a genetically predetermined way of cell decay. It is therefore a counterpart to tissue proliferative activity. The integrity of a multicellular organism is determined by dynamic balance between the production of new cells and the decay of other cells. This allows to maintain an optimal number of cells in tissues with a different proliferative activity throughout ontogenesis and in postnatal life. Cell death thus becomes a normal and essential part of morphogenesis. The significance of apoptosis in some cardiovascular diseases is described: hypertension, ischaemic heart disease, heart failure, cardiomyopathy and heart graft rejection.

Keywords: apoptosis; pathogenesis; cardiovascular diseases

Received: February 1, 2005; Accepted: March 11, 2005; Published: October 1, 2005  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Hude P. The role of apoptosis in cardiovascular diseases. Vnitr Lek. 2005;51(10):1114-1119.
Download citation

References

  1. Ashkenazi A, Dixit VM. Death receptors: signaling and modulation. Science 1998; 281: 1305-1308. Go to original source... Go to PubMed...
  2. Bergese SD, Klenotic SM, Wakely ME et al. Apoptosis in murine cardiac grafts. Transplantation 1997; 63: 320. Go to original source... Go to PubMed...
  3. Buja LM, Entman ML Modes of myocardial injury and cell death in ischemic heart diseases. Circulation 1998; 98: 1355-1357. Go to original source... Go to PubMed...
  4. Conrad CH, Brooks WW, Hayes JA et al. Myocardial fibrosis and stiffness with hypertrophy and heart failure in the spontaneously hypertensive rat. Circulation 1995; 91: 161-170. Go to original source... Go to PubMed...
  5. Díez J, Panizo A, Hernández M et al. Cardiomyocyte apoptosis and angiotensin-converting enzyme in spontaneously hypertensive rats. Hypertension 1997; 30: 1029-1034. Go to original source... Go to PubMed...
  6. Duke RC, Ojcius DM, Young JDE. Cell suicide in health and disease. Sci Am 1996; 275: 80-87. Go to original source... Go to PubMed...
  7. Fliss H, Gattinger D. Apoptosis in ischemic and reperfused rat myocardium. Circ Res 1996; 79: 949-956. Go to original source... Go to PubMed...
  8. Fortuno MA, González A, Ravassa S et al. Clinical implications of apoptosis in hypertensive heart disease. Am J Heart Circ Physiol 2003; 284: H1495-H1506. Go to original source... Go to PubMed...
  9. González A, López B, Ravassa S et al. Stimulation of cardiac apoptosis in essential hypertension: potential role of angiotensin II. Hypertension 2002; 39: 75-80. Go to original source... Go to PubMed...
  10. González A, Fortuno M, Querejeta R et al. Cardiomyocyte apoptosis in hypertensive cardiomyopathy. Cardiovasc Res 2003; 59: 549-562. Go to original source... Go to PubMed...
  11. Gottlieb RA, Burleson KO, Kloner RA et al. Reperfusion injury induces apoptosis in rabbit cardiomyocytes. J Clin Invest 1994; 94: 1621-1628. Go to original source... Go to PubMed...
  12. Goussev A, Sharov VG, Shimoyama H et al. Effects of ACE inhibition on cardiomyocyte apoptosis in dogs with chronic heart failure. Am J Physiol 1998; 275: H626-H631. Go to original source... Go to PubMed...
  13. Grüter MG. Caspases: key players in programmed cell death. Curr Opin Cell Biol 2000; 10: 649-655. Go to original source...
  14. Hinescu ME. Cardiac apoptosis: from organ failure to allograft rejection. J Cell Mol Med 2001; 5: 143-152. Go to original source... Go to PubMed...
  15. Horký K. Patofyziologický význam apoptózy u kardiovaskulárních onemocnění. Cor Vasa 1999; 41: 31-34.
  16. Hökl J, Černý J, Němec P et al. Apoptóza periferních T lymfocytů během imunosuprese s použitím Neoralu nebo Tacrolimu a během rejekčních epizod a jejich léčba u příjemců srdečního štěpu. Cor Vasa 2004; 46: 343-345.
  17. Hude P, Horký M, Krejčí J et al. Apoptosis plays role in cellular rejection after human heart transplantation. European Journal of Heart Failure 2004; 3S: 9. Go to original source...
  18. James TN. Normal and abnormal consequences of apoptosis in the human heart. From postnatal morphogenesis to paroxysmal arrhythmias. Circulation 1994; 90: 556-573. Go to original source...
  19. Kanoh M, Takemura G, Misao J et al. Significance of myocytes with positive DNA in situ nick end-labelling (TUNEL) in hearts with dilated cardiomyopathy. Circulation 1999; 99: 2757-2764. Go to original source... Go to PubMed...
  20. Kerr JFR. Shrinkage necrosis: distinc mode of cellular death. J Pathol 1971; 105: 13-20. Go to original source... Go to PubMed...
  21. Kluck RM, Bossy-Wetzel E, Green DR et al. The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science 1997; 275: 1132-1136. Go to original source... Go to PubMed...
  22. Kroemer G, Reed JC. Mitochondrial control of cell death. Nature Med 2000; 6: 513-519. Go to original source... Go to PubMed...
  23. Laguens RP, Meckert PM, Martino JS et al. Identification of programmed cell death (apoptosis) in situ by labeling of nuclear DNA fragments in heart biopsy samples during acute rejection episodes. J Heart Lung Transplant 1996; 15: 911.
  24. Li Z, Bing OH, Long X et al. Increased cardiomyocyte apoptosis during the transition to heart failure in the spontaneously hypertensive rat. Am J Pathol 1997; 272: H2313-H2319. Go to original source... Go to PubMed...
  25. Mallat Z, Tedgui A, Fontaliran F et al. Evidence of apoptosis in arrhythmogenic right ventricular dysplasia. New Engl J Med 1996; 335: 1190-1196. Go to original source... Go to PubMed...
  26. Narula J, Acio ER, Narula N el al. Annexin-V imaging for noninvasive detection of cardiac allograft rejection. Nat Med 2001; 7: 1347-1352. Go to original source... Go to PubMed...
  27. Narula J, Haider N, Virmani R et al. Apoptosis in myocytes in end-stage heart failure. New Engl J Med 1996; 335: 1182-1189. Go to original source... Go to PubMed...
  28. Nováčková K, Aschermann M et al. Současný pohled na patofyziologii srdečního selhání. Cor Vasa 2000; 42: 178-184.
  29. Novosad J, Kodydková K, Krejsek J. Apoptóza, její mechanismy a medicínský význam. I.Definice apoptózy a její průběh na buněčné úrovni. Vnitř Lék 2001; 47: 381-386. Go to PubMed...
  30. Novosad J, Kodydková K, Krejsek J. Apoptóza, její mechanismy a medicínský význam. II. Poruchy regulace apoptózy a jejich souvislost s rozvojem onemocnění. Vnitř Lék 2001; 47: 387-390. Go to PubMed...
  31. Ohno M, Takemura G, Ohno A et al. "Apoptotic" myocytes in infarct area in rabbit hearts may be oncotic myocytes with DNA fragmentation. Circulation 1998; 98: 1422-1430. Go to original source... Go to PubMed...
  32. Olivetti G, Abbi R, Quaini F et al. Apoptosis in the failing human heart. N Engl J Med 1997; 336: 1131-1141. Go to original source... Go to PubMed...
  33. Olivetti G, Maestri R, Cigola E et al. Does apoptosis play a role in the progression of heart failure? Dialogues in Cardio Med 1998; 2: 91-94.
  34. Saraste A, Pulkki K, Kallajoki M et al. Apoptosis in human acute myocardial infarction. Circulation 1997; 95: 320-323. Go to original source... Go to PubMed...
  35. Scarabelli TM, Knight RA, Rayment NB et al. Quantitative assessment of cardiac myocyte apoptosis in tissue sections using the fluorescent-based TUNEL technique enhanced with counterstains. J Immunol Methods 1999; 228: 23-28. Go to original source... Go to PubMed...
  36. Sharov VG, Sabbah HN, Shimoyama H et al. Evidence of cardiomyocyte apoptosis in myocardium of dogs with chronic heart failure. Am J Pathol 1996; 148: 141-149.
  37. Szabolcs M, Ravalli S, Minanov O et al. Apoptosis and increased expression of nitric oxide synthase in human allograft rejection. Transplantation 1998; 65: 804. Go to original source... Go to PubMed...
  38. Takemura G, Ohno M, Hayakawa Y et al. Role of apoptosis in the disappearance of infiltrated and proliferated interstitial cells after myocardial infarction. Circ Res 1998; 82: 1130-1138. Go to original source... Go to PubMed...
  39. Toller WG, Kersten JR, Pagel PS et al. Sevoflurane reduces myocardial infarct size and decreases the time threshold for ischemic preconditioning in dogs. Anesthesiol 1999; 91: 1437-1446. Go to original source... Go to PubMed...
  40. Toyozaki T, Hiroe M, Tanaka M et al. Levels of soluble Fas ligand in myocyarditis Am J Cardiol 1998; 82: 246-248. Go to original source... Go to PubMed...
  41. Umlauf J, Horký M. Molecular biology of doxorubicin-induced cardiomyopathy. Experimental and Clinical Cardiology 2002; 7: 35-39.
  42. Van Hoffen E, Van Wichen DF, Leemans JC et al. T cell apoptosis in human heart allografts: Association with lack of co-stimulation. Am J Pathol 1998; 153: 813. Go to original source... Go to PubMed...
  43. Wagner R, Piler P, Horváth R et al. Význam apoptózy v myokardiální tkáni po reperfuzi v kardiochirurgii. Cor Vasa 2004; 46: 24-28.
  44. Yaoita H, Ogawa K, Maehara K et al. Apoptosis in relevant clinical situations: contribution of apoptosis in myocardial infarction. Cardiovasc Res 2000; 45: 630-641. Go to original source... Go to PubMed...
  45. Yet ET. Life and death in the cardiovascular system. Circulation 1997; 95: 782-786. Go to original source... Go to PubMed...
  46. Yue TL, Ma XL, Chen XS et al. Carvedilol prevents cardiac ischemic damage and apoptosis in rabbit cardiomyocytes (Abstr). Circulation 1996; 94: I-226.
  47. Zamzami N, Susin SA, Marcheti P et al. Mitochondrial control of nuclear apoptosis. J Exp Med 1996; 183: 1533-1544. Go to original source... Go to PubMed...
  48. Zhao Z, Nakamura M, Wang N et al. Reperfusion induces myocardial apoptotic cell death. Cardiovasc Res 2000; 45: 651-660. Go to original source... Go to PubMed...
  49. Ziori CH, Zioris CH, Kyriakidis M. Apoptosis in heart failure. Hellenic J Card 2003; 44: 56-70.




Vnitřní lékařství

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.